NCT03530722View on ClinicalTrials.gov

Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

July 4, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

December 11, 2017

Conditions
Breast Cancer
Trial Locations (1)

8008

Brust-Zentrum AG, Zurich

All Listed Sponsors
lead

Brust-Zentrum AG

OTHER

NCT03530722 - Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies | Biotech Hunter | Biotech Hunter